Spikevax XBB.1.5
0.1 mg/mL formulation
Spikevax XBB.1.5 is indicated for active immunisation to prevent COVID-19 disease caused by SARS- CoV-2 in individuals 6 months of age and older.
Patient Information Leaflet
Patient Information Leaflet
Summary of Product Characteristics
Summary of Product Characteristics
Tools
Temperature Excursion Tool
Temperature Excursion Tool
See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.
Report Adverse Events
Report Adverse Events
You can report any adverse events to Moderna via the Adverse Event Intake Portal or by calling 1-800-622-4937.
Contact Moderna
8am-5pm SST – Mon - Fri
APACmedinfo@modernatx.com